Novosti
Khirurgii
This journal is
indexed in Scopus









Year 2010 Vol. 18 No 1

ONCOLOGY

A.A. KASYUK

RETROSPECTIVE ANALYSIS OF ANTICOAGULATING PROPHYLAXIS IN ONCOLOGICAL PATIENTS, DIED OF THE PULMONARY EMBOLISM IN THE POSTOPERATIVE PERIOD

100 cancer patients who died in the postoperative period of the pulmonary embolism (PE) verified by autopsy were included in this original research. From the total 100 patients anticoagulants were prescribed for 64, low molecular weight heparins were administered to 63 of them. Prescription of the anticoagulants decreases postoperative venous thrombotic complications rate, but doesnt allows protecting the patients from their development in all cases.

Keywords: pulmonary embolism, anticoagulant prevention, postoperative period
p. 75 79 of the original issue
References
  1. Donati, M. B. Cancer and thrombosis: from phlegmasia alba to transgenic mice / M. B. Donati // Thromb. Haemost. 1995. Vol. 74. P. 278-281.
  2. Outcomes and cost of deep vein thrombosis among patients with cancer / L. S. Elting [et al.] // Arch. Intern. Med. 2004. Vol. 164. P. 1653-1661.
  3. Kakkar, A. K. Prevention of venous thrombo-embolism in cancer patients / A. K. Kakkar, R. C. N. Williamson // Semin. Thromb. Hemost. 1999. Vol. 25. P. 239-243.
  4. Prandoni, P. Cancer and thromboembolic disease: how important is the risk of thrombosis? / P. Prandoni // Cancer Treat. Rev. 2002. Vol. 28, N 3. P. 133-136.
  5. Clagett, G. P. Prevention of venous thrombo-embolism in general surgical patients. Results of meta-analysis / G. P. Clagett, J. S. Reisch // Ann. Surg. 1988. Vol. 208. P. 227-240.
  6. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin / R. Collins [et al.] // N. Engl. J. Med. 1988. Vol. 318. P. 1162-1173.
  7. Postoperative pulmonary embolism after hospital discharge. An underestimated risk / O. Huber [et al.] // Arch. Surg. 1992. Vol. 127. P. 310-313.
  8. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients / D. Bergqvist [et al.] // Br. J. Surg. 1995. Vol. 82. P. 496-501.
  9. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer / D. Bergqvist [et al.] // N. Engl. J. Med. 2002. Vol. 346. P. 975-980.
  10. Khorana, A. A. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: Strategies for Improving VTE Prophylaxis in Hospitalized Cancer Patients / A. A. Khorana // The Oncologist. 2006. Vol. 12, N 11. P. 1361-1370.
  11. American Society of Clinical Oncology Guidelines: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer / G. H. Lyman [et al.] // J. Clin. Oncol. 2007. Vol. 25, N 34. P. 5490-5505.
  12. Prevention of venous thromboembolism. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) / W. H. Geerts [et al.] // Chest. 2008. Vol. 133, N 6. Suppl. P. 381-453.
  13. Clagett, G. P. Prevention of venous thrombo-embolism in general surgical patients. Results of meta-analysis / G. P. Clagett, J. S. Reish // Ann. Surg. 1988. Vol. 208. P. 227-240.
  14. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery / R. Collins [et al.] // N. Engl. J. Med. 1988. Vol. 318. P. 1162-1173.
Contacts | ©Vitebsk State Medical University, 2007